
Sign up to save your podcasts
Or


Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
By Michael Putman4.9
113113 ratings
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643

323 Listeners

498 Listeners

878 Listeners

131 Listeners

1,145 Listeners

121 Listeners

191 Listeners

172 Listeners

67 Listeners

247 Listeners

4 Listeners

183 Listeners

11 Listeners

18 Listeners

6 Listeners